Rugby Resources Ltd. (RBMNF)

Elevation Oncology Cash Flow Statement

Financials in millions CAD. Fiscal year is March - February.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Net Income	-3.08	-3.46	-13	-2.71	-1.09
Depreciation & Amortization	-	-	6.96	0.06	0.01
Stock-Based Compensation	0.09	0.43	0.56	0.28	0.19
Other Operating Activities	0.01	-0.02	0.01	0.05	0.03
Change in Accounts Receivable	0.04	-0.03	0.03	-0.03	0.03
Change in Accounts Payable	0.04	-0.15	0.02	0.07	0
Change in Other Net Operating Assets	0.1	-0.04	-0.04	0.13	-0
Operating Cash Flow	-2.8	-3.27	-5.47	-2.15	-0.83
Capital Expenditures	-	-	-	-0.17	-
Investing Cash Flow	-	-	-	-0.17	-
Long-Term Debt Issued	1	-	0.06	0.09	0.04
Long-Term Debt Repaid	-	-0.03	-0.14	-0.32	-0.01
Net Debt Issued (Repaid)	1	-0.03	-0.08	-0.23	0.03
Issuance of Common Stock	1.34	4.27	3.66	4.57	0.68
Other Financing Activities	-0.04	-0.16	-0.02	-0.21	-0.01
Financing Cash Flow	2.29	4.08	3.55	4.14	0.7
Foreign Exchange Rate Adjustments	-0	0.04	0.04	-0.01	-0
Miscellaneous Cash Flow Adjustments	-0.03	-0.1	-	-	-
Net Cash Flow	-0.54	0.75	-1.88	1.82	-0.14
Free Cash Flow	-2.8	-3.27	-5.47	-2.32	-0.83
Free Cash Flow Per Share	-0.01	-0.01	-0.03	-0.02	-0.01
Levered Free Cash Flow	-0.44	-0.53	-0.53	-1.15	-0.41
Unlevered Free Cash Flow	-0.44	-0.53	-0.53	-1.15	-0.41
Change in Net Working Capital	-0.09	0.21	-0.01	-0.33	-0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.